Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Houston’s high-stakes mayoral duel ends with John Whitmire claiming throne In a defining moment for Houston’s political landscape, Texas state Senator John Whitmire has been projected by NBC… byPallavi MadhirajuDecember 10, 2023